Central Jersey Blood Center, Inc. FDA Inspection Record
Central Jersey Blood Center, Inc. is an FDA-inspected facility (FEI 2270821) located in Shrewsbury, NJ, US. RegDataLab tracks 5 FDA inspections at this facility.
What FDA found at this site
- Latest inspection
- Mar 2, 2017: No Action Indicated (NAI)
- Inspections on record
- 5 (1 VAI, 4 NAI)
- Last OAI inspection
- None on record
- Warning letters
- None matched to this FEI. Many letters do not state an FEI: search warning letters by company name
- Recalls as the recalling firm
- 20, latest Jul 5, 2007
Inspections and what FDA cited
| Date | Result | What FDA cited |
|---|---|---|
| Mar 2, 2017 | No Action Indicated (NAI) | No citations listed |
| Nov 4, 2014 | No Action Indicated (NAI) | No citations listed |
| Mar 12, 2013 | No Action Indicated (NAI) | No citations listed |
| Jun 16, 2011 | No Action Indicated (NAI) | No citations listed |
| Jul 10, 2009 | Voluntary Action Indicated (VAI) | Suitable size, construction, etc. (21 CFR 606.40) Provide space for examination (21 CFR 606.40(a)(1)) Establish, maintain and follow manufacturing SOPs (21 CFR 606.100(b)) |
Recalls
| Date | Class | Recall | Product and reason |
|---|---|---|---|
| Jul 5, 2007 | Class II | B-0798-08 | Platelets Pheresis Leukocytes Reduced Irradiated Blood product, which was possibly contaminated with Propionibacterium Acnes, was distributed. |
| Apr 10, 2007 | Class II | B-0744-08 | Platelets Pheresis Leukocytes Reduced Blood product, which was possibly contaminated with Propionibacterium acnes, was distributed. |
| Mar 9, 2007 | Class II | B-0797-08 | Platelets Pheresis Leukocytes Reduced Blood products, which were possibly contaminated with Propionibacterium Acnes, were distributed. |
| Feb 21, 2007 | Class II | B-1503-07 | Fresh Frozen Plasma (Apheresis) Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed. |
| Dec 4, 2006 | Class II | B-1450-07 | Red Blood Cells Leukocytes Reduced Irradiated Blood products, which were collected from a donor who had traveled to a malarial endemic area, were distributed. |
| Nov 29, 2006 | Class II | B-1481-07 | Platelets Pheresis Leukocytes Reduced Irradiated Blood products, which were collected from a donor who had traveled to a malarial endemic area, were distributed. |
| Apr 28, 2006 | Class II | B-0328-08 | Red Blood Cells Leukocytes Reduced and 1 more product Blood product, collected from a donor considered to be at increased risk for variant Creutzfeldt-Jakob Disease (vCJD), was distributed. |
| Aug 8, 2005 | Class II | B-1605-07 | Recovered Plasma Blood product, which was collected from an unsuitable donor based on risk factors for variant Creutzfeldt-Jakob Disease (vCJD), was… |
| Mar 31, 2004 | Class II | B-1449-5 | Red Blood Cells (Apheresis) and 1 more product Blood products, collected on an instrument that had not been validated for use, were distributed. |
| Feb 5, 2004 | Class III | B-1990-5 | Red Blood Cells Blood products, collected from a donor whose temperature was not documented, were distributed. |
FDA record score
0 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.
16 records behind this number
| Record | Date | Points x age weight | Adds |
|---|---|---|---|
| Inspection classified VAI | Jul 10, 2009 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0798-08, this FEI as the recalling firm | Jul 5, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0744-08, this FEI as the recalling firm | Apr 10, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0797-08, this FEI as the recalling firm | Mar 9, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1503-07, this FEI as the recalling firm | Feb 21, 2007 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1450-07, this FEI as the recalling firm | Dec 4, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1481-07, this FEI as the recalling firm | Nov 29, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0328-08, this FEI as the recalling firm | Apr 28, 2006 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1605-07, this FEI as the recalling firm | Aug 8, 2005 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1449-5, this FEI as the recalling firm | Mar 31, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1991-5, this FEI as the recalling firm | Feb 5, 2004 | 10 years or older, so it adds no points | 0 |
| Class II recall B-2436-5, this FEI as the recalling firm | Mar 28, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-1992-5, this FEI as the recalling firm | Mar 17, 2003 | 10 years or older, so it adds no points | 0 |
| Class I recall B-1180-3, this FEI as the recalling firm | Jan 23, 2003 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0931-3, this FEI as the recalling firm | Jul 29, 2002 | 10 years or older, so it adds no points | 0 |
| Class II recall B-0997-3, this FEI as the recalling firm | Jun 25, 2001 | 10 years or older, so it adds no points | 0 |
When each source was last refreshed
| Records | Last refreshed | Source as of | Status |
|---|---|---|---|
| Inspections | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Inspection citations | Nov 16, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions (warning letters, injunctions and other action types) | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
| Warning letter text | Nov 16, 2026 | Newest record Nov 10, 2026 | Current |
| Recalls (Enforcement Report) | Nov 16, 2026 | Newest record Nov 11, 2026 | Current |
| Form 483s and inspection documents | Nov 13, 2026 | Newest record Nov 12, 2026 | Current |
| Import refusals | Nov 15, 2026 | Newest record Nov 5, 2026 | Current |
Reviewing Central Jersey Blood Center, Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Central Jersey Blood Center, Inc. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Facility details
- Company
- Central Jersey Blood Center, Inc.
- Location
- Shrewsbury, NJ (US)
- Source
- inspections